Levetiracetam Stada Arzneimittel

Levetiracetam, the active ingredient in Levetiracetam Stada Arzneimittel, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic and myoclonic seizures.

GNH USA supplies Levetiracetam Stada Arzneimittel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to control seizure activity across several epilepsy syndromes.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: decreases sudden muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue - Dizziness - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as neutropenia - Suicidal thoughts or behavior - Severe depression or mood changes - Rash with systemic involvement

Before initiating therapy, consider the following precautions.

Renal impairment: adjust dose as recommended by the prescriber. Hepatic dysfunction: monitor liver function tests regularly. Psychiatric symptoms: observe for mood changes, depression or suicidal ideation. Pregnancy: discuss potential risks with a healthcare professional. Driving: avoid operating machinery until individual response is known. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Levetiracetam can interact with other medicines; review the following.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Enzyme‑inducing antiepileptics (e.g., phenobarbital, phenytoin): may lower efficacy. - Strong CYP450 inhibitors: potential increase in levetiracetam concentration.

Moderate Interactions (Monitor Closely): - Other CNS depressants: may enhance sedation or dizziness. - Antidepressants: monitor for mood alterations. - Renally cleared drugs: adjust dosing if renal function changes.